Abstract: Amisulpride is useful in the treatment of postoperative nausea and/or vomiting in a patient, wherein the patient has already been administered a prophylaxis drug for postoperative nausea and/or vomiting, and wherein the dose of amisulpride is 7.5 to 15 mg.
Type:
Application
Filed:
May 2, 2024
Publication date:
August 29, 2024
Applicant:
ACACIA PHARMA LTD
Inventors:
Julian Clive Gilbert, Robert Gristwood, Gabriel Fox
Abstract: Amisulpride is useful in the treatment of postoperative nausea and/or vomiting in a patient, wherein the patient has already been administered a prophylaxis drug for postoperative nausea and/or vomiting, and wherein the dose of amisulpride is 7.5 to 15 mg.
Type:
Grant
Filed:
May 17, 2022
Date of Patent:
June 11, 2024
Assignee:
Acacia Pharma Ltd.
Inventors:
Julian Clive Gilbert, Robert William Gristwood, Gabriel Fox
Abstract: Amisulpride is useful in the therapy (particularly the prevention of) post-operative nausea and/or vomiting (PONV) in a patient, particularly wherein the patient has a high (?30) BMI and/or the patient is a bariatric surgery patient.
Type:
Application
Filed:
July 6, 2021
Publication date:
August 24, 2023
Applicant:
ACACIA PHARMA LTD
Inventors:
Julian Clive GILBERT, Gabriel FOX, Robert William GRISTWOOD
Abstract: Amisulpride is useful in the treatment of postoperative nausea and/or vomiting in a patient, wherein the patient has already been administered a prophylaxis drug for postoperative nausea and/or vomiting, and wherein the dose of amisulpride is 7.5 to 15 mg.
Type:
Grant
Filed:
February 9, 2018
Date of Patent:
June 14, 2022
Assignee:
Acacia Pharma Ltd
Inventors:
Julian Clive Gilbert, Robert William Gristwood, Gabriel Fox
© 2025 Justia
